Premium
Advances in dihydroetorphine: From analgesia to detoxification
Author(s) -
BoYi Qin
Publication year - 1996
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/(sici)1098-2299(199610)39:2<131::aid-ddr3>3.0.co;2-q
Subject(s) - detoxification (alternative medicine) , heroin , analgesic , abstinence , narcotic , medicine , drug , pharmacology , intensive care medicine , anesthesia , psychiatry , alternative medicine , pathology
Dihydroetorphine is the first narcotic analgesic successfully developed and approved for production in China. As an analgesic, it has been used safely and effectively in clinical practice for 12 years. In recent years, it has been used successfully for substitution therapy in detoxification from opiates. As a drug for detoxification from opiates, the main advantages of DHE are its quick onset of effect and thorough control of the abstinence symptoms. DHE can detoxify heroin dependence in 7–10 days and does not cause dependence in reasonable therapeutic regimens. Drug Dev. Res. 39:131–134. © 1997 Wiley‐Liss, Inc.